+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bicyclic Peptide Market - Global Forecast 2026-2032- Product Image
Bicyclic Peptide Market - Global Forecast 2026-2032- Product Image
New

Bicyclic Peptide Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6119069
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior industry executives navigating the evolving peptide therapeutics space will find the bicyclic peptide market positioned for robust and sustained growth, as innovative modalities and collaborative strategies align with shifting regulatory and commercial realities.

Market Snapshot: Bicyclic Peptide Market Growth Outlook

The Bicyclic Peptide Market expanded from USD 385.47 million in 2025 to USD 434.77 million in 2026 and is on track to reach USD 985.47 million by 2032. This growth is driven by increasing adoption of bicyclic peptide platforms that bridge the advantages of small molecules and biologics. A compound annual growth rate (CAGR) of 14.34% reflects strong momentum across applications, from early discovery through clinical translation. Interest from large pharmaceutical companies, as well as specialized biotech firms, is fueling an uptick in technology investment and cross-sector partnerships.

Bicyclic Peptide Market Scope & Segmentation

This report provides comprehensive coverage of the key divisions shaping the future of bicyclic peptides:

  • Applications: Diagnostics, drug discovery, and therapeutic use, with further sub-segmentation in therapeutic areas such as cardiovascular, oncology (hematologic and solid tumor), and infectious diseases.
  • Product Architectures: Includes bicyclic, linear, monocyclic, and multicyclic peptides, distinguished by linker chemistries like amide, ester, and thioether.
  • Technology Platforms: Encompasses mRNA display, phage display (including M13 and T7 systems), split-and-pool, and yeast display, each offering different advantages in diversity and hit selection.
  • Routes of Administration: Inhalation, oral, topical, and injectable (subcutaneous, intramuscular, intravenous), impacting design and formulation approaches.
  • End Users: Academic and research institutions, pharmaceutical and biotechnology companies (from global leaders to emerging biotechs), and contract research organizations.
  • Sales Channels: Direct sales, distribution partnerships, and a growing e-commerce footprint, including both marketplaces and dedicated vendor sites.
  • Geographical Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific—each with distinct innovation ecosystems, regulatory frameworks, and manufacturing strengths.

Key Takeaways for Senior Decision-Makers

  • Bicyclic peptides offer a modality that overcomes the specificity and stability limitations seen in earlier peptide or small molecule approaches.
  • Advancements in cyclization chemistries and display platforms enable rapid iteration and custom design, fostering new partnerships between synthetic chemistry, computational teams, and biologics-focused developers.
  • Regulatory scrutiny and payer demands are shifting focus to translational endpoints and manufacturing feasibility, prompting earlier consideration of biomarker strategy and supply chain resilience.
  • Strategic collaborations—ranging from licensing and co-development to manufacturing alliances—are structuring the competitive landscape, with clear differentiation on platform technologies and intellectual property positions now central to deal value.
  • Segment-level insights help prioritize R&D investments and partner selection, as application, therapeutic area, and route of administration each drive unique development and commercialization considerations.
  • Integrated sourcing strategies, secondary supplier qualification, and regional manufacturing capabilities are becoming critical for sustaining program momentum and insulating against global trade uncertainties.

Bicyclic Peptide Market: Tariff Impact and Supply Chain Implications

Recent tariff policies have affected global access to high-purity inputs and laboratory equipment. Companies are diversifying supplier bases and reconsidering manufacturing geographies to mitigate increased costs and operational risk. The need for resilient procurement and inventory strategies is altering how organizations approach both short-term supply and long-term partner relationships. Regulatory compliance burdens and customs complexities have also amplified, affecting project timelines and the structure of international collaborations.

Methodology & Data Sources

Findings in this report are grounded in a triangulated approach combining expert interviews, peer-reviewed literature analysis, and review of company disclosures and regulatory records. This integrated methodology ensures a balanced perspective across small biotech innovators, contract development organizations, and established pharmaceutical developers, with sensitivity checks included to account for known uncertainties.

Why This Report Matters for the Bicyclic Peptide Market

  • Delivers actionable insights on technology, supply chain, and partnership dynamics to inform strategic portfolio and sourcing decisions.
  • Enables benchmarking against competitor strategies, segment prioritization, and evolving regulatory or payer requirements in key geographies.
  • Supports commercial planning with empirically grounded forecasts and tangible risk management guidance—critical for translating scientific innovation into market access and revenue growth.

Conclusion

Bicyclic peptides are carving out a prominent role in drug discovery and therapeutics, backed by platform innovation and adaptive commercial strategies. Senior decision-makers who align scientific, operational, and partnership priorities will be best positioned to capture value and drive successful market entry.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bicyclic Peptide Market, by Product Type
8.1. Bicyclic Peptide
8.1.1. Amide Linker
8.1.2. Ester Linker
8.1.3. Thioether Linker
8.2. Linear Peptide
8.3. Monocyclic Peptide
8.4. Multicyclic Peptide
9. Bicyclic Peptide Market, by Therapeutic Area
9.1. Cardiovascular Diseases
9.2. Infectious Diseases
9.3. Inflammatory Disorders
9.4. Oncology
10. Bicyclic Peptide Market, by Technology Platform
10.1. MRNA Display
10.2. Phage Display
10.3. Split-and-Pool
10.4. Yeast Display
11. Bicyclic Peptide Market, by Route Of Administration
11.1. Inhalation
11.2. Injectable
11.2.1. Intramuscular
11.2.2. Intravenous
11.2.3. Subcutaneous
11.3. Oral
11.4. Topical
12. Bicyclic Peptide Market, by Application
12.1. Diagnostics
12.2. Drug Discovery
12.3. Therapeutics
12.3.1. Cardiovascular Diseases
12.3.2. Infectious Diseases
12.3.3. Oncology
12.3.3.1. Hematologic Cancers
12.3.3.2. Solid Tumors
13. Bicyclic Peptide Market, by End User
13.1. Academic & Research Institutes
13.2. Contract Research Organizations
13.3. Pharmaceutical & Biotechnology Companies
13.3.1. Big Pharma
13.3.2. Early-Stage Biotech
14. Bicyclic Peptide Market, by Sales Channel
14.1. Online
14.2. Offline
15. Bicyclic Peptide Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Bicyclic Peptide Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Bicyclic Peptide Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Bicyclic Peptide Market
19. China Bicyclic Peptide Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. AbbVie Inc.
20.6. Amgen Inc.
20.7. AstraZeneca PLC
20.8. Bicycle Therapeutics plc
20.9. Boehringer Ingelheim International GmbH
20.10. Bristol Myers Squibb Company
20.11. Eli Lilly and Company
20.12. Genentech, Inc.
20.13. GlaxoSmithKline plc
20.14. Johnson & Johnson
20.15. Merck & Co., Inc.
20.16. Novo Nordisk A/S
20.17. PeptiDream Inc.
20.18. Pfizer Inc.
20.19. Sanofi
20.20. Servier Laboratories
20.21. Takeda Pharmaceutical Company Limited
20.22. Vertex Pharmaceuticals Incorporated
List of Figures
FIGURE 1. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BICYCLIC PEPTIDE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BICYCLIC PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY AMIDE LINKER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY AMIDE LINKER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY AMIDE LINKER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ESTER LINKER, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ESTER LINKER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ESTER LINKER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THIOETHER LINKER, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THIOETHER LINKER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THIOETHER LINKER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY LINEAR PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY LINEAR PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY LINEAR PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MONOCYCLIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MONOCYCLIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MONOCYCLIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MULTICYCLIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MULTICYCLIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MULTICYCLIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFLAMMATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFLAMMATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MRNA DISPLAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MRNA DISPLAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MRNA DISPLAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SPLIT-AND-POOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SPLIT-AND-POOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SPLIT-AND-POOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY YEAST DISPLAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY YEAST DISPLAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY YEAST DISPLAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY HEMATOLOGIC CANCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY HEMATOLOGIC CANCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BIG PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY EARLY-STAGE BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY EARLY-STAGE BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY EARLY-STAGE BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 181. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 182. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 183. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 190. EUROPE BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 207. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 208. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 209. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 211. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 213. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 214. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 216. AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 234. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 235. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 236. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 238. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 240. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 243. ASEAN BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. GCC BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. GCC BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 246. GCC BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 247. GCC BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 248. GCC BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 249. GCC BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 250. GCC BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 251. GCC BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. GCC BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 253. GCC BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 254. GCC BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. GCC BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 256. GCC BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 273. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 274. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 275. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 277. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 279. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 280. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 282. BRICS BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. G7 BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. G7 BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. G7 BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 286. G7 BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 287. G7 BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 288. G7 BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. G7 BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 290. G7 BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 291. G7 BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 292. G7 BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 293. G7 BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. G7 BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 295. G7 BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 296. NATO BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. NATO BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 298. NATO BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 299. NATO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 300. NATO BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 301. NATO BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. NATO BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 303. NATO BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 304. NATO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 305. NATO BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 306. NATO BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 307. NATO BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 308. NATO BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 309. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 323. CHINA BICYCLIC PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 324. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 325. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 326. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 327. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 328. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 329. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 330. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 331. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 332. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 333. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 334. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 335. CHINA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bicycle Therapeutics plc
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Genentech, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • Sanofi
  • Servier Laboratories
  • Takeda Pharmaceutical Company Limited
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 434.77 Million
Forecasted Market Value ( USD ) by 2032 $ 985.47 Million
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Reports

Bicyclic Peptide Drug Conjugates Market - Global Forecast 2026-2032 - Product Image

Bicyclic Peptide Drug Conjugates Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms & Market Opportunity Insight 2025 - Product Image

Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms & Market Opportunity Insight 2025

  • Report
  • 55 Pages
  • Global
From
Norbornadiene Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Norbornadiene Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 68 Pages
  • Global
From
Constrained Peptide Drugs Market - Global Forecast 2026-2032 - Product Image

Constrained Peptide Drugs Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Peptide Drug Conjugates Market Report 2025 - Product Image

Peptide Drug Conjugates Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.